A Randomized, Double-Blind, Three Period, Cross-Over Study to Evaluate the Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan (Imitrex) in Healthy Male and Female Subjects
Phase of Trial: Phase I
Latest Information Update: 03 Dec 2019
Price : $35 *
At a glance
- Drugs Lasmiditan (Primary) ; Sumatriptan
- Indications Migraine
- Focus Adverse reactions; Pharmacodynamics
- Sponsors CoLucid Pharmaceuticals; Eli Lilly and Company
- 10 May 2017 Status changed from recruiting to completed.
- 16 Mar 2017 Status changed from not yet recruiting to recruiting.
- 15 Mar 2017 New trial record